Seres Therapeutics Inc (MCRB) — Cash Flow Quality Index
Seres Therapeutics Inc (MCRB) has a Cash Flow Quality Index of 0.27x as of September 2025. Operating cash flow of $2.21 Million is below net income of $8.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Seres Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seres Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Seres Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Seres Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Seres Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Seres Therapeutics Inc. For live market cap and the full company financial profile, see MCRB market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1092.71x | $-148.61 Million | $136.00K | — |